Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
11.45
+0.29 (2.60%)
At close: Jun 6, 2025, 4:00 PM
11.59
+0.14 (1.22%)
After-hours: Jun 6, 2025, 5:35 PM EDT
Syndax Pharmaceuticals Employees
Syndax Pharmaceuticals had 270 employees as of December 31, 2024. The number of employees increased by 86 or 46.74% compared to the previous year.
Employees
270
Change (1Y)
86
Growth (1Y)
46.74%
Revenue / Employee
$161,933
Profits / Employee
-$1,226,681
Market Cap
985.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
SNDX News
- 2 days ago - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Syndax Announces Participation in June Investor Conferences - GlobeNewsWire
- 24 days ago - Syndax Announces Data Presentations at EHA 2025 Showcasing Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) - GlobeNewsWire
- 26 days ago - Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer - GlobeNewsWire
- 4 weeks ago - Syndax Announces Participation in May Investor Conferences - GlobeNewsWire
- 4 weeks ago - Syndax Announces Publication of Pivotal Revumenib Data in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia in the Journal Blood - GlobeNewsWire
- 4 weeks ago - Syndax Pharmaceuticals, Inc. (SNDX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Syndax Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire